MGCD290 and Fluconazole Versus Fluconazole Alone for the Treatment of Moderate to Severe Vulvovaginal Candidiasis
- First Posted Date
- 2011-12-22
- Last Posted Date
- 2013-04-04
- Lead Sponsor
- MethylGene Inc.
- Target Recruit Count
- 220
- Registration Number
- NCT01497223
- Locations
- 🇺🇸
Brownstone Clinical Trials, Irving, Texas, United States
🇺🇸Clinical Trials Management, Covington, Louisiana, United States
🇺🇸Lyndhurst Clinical Research, Winston-Salem, North Carolina, United States
© Copyright 2025. All Rights Reserved by MedPath